Jack danielAccording to MarkNtel Advisors study the Global Cell-based Assay Market is anticipated to grow at a CAGR of around 8.4% during the forecast period, i.e., 2024-29.
“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn’t take long for the team to deliver the most recent version of the report.”
Access Free Sample Report – https://www.marknteladvisors.com/query/request-sample/cell-based-assay-market.html
Key Findings of the Study: Cell-based Assay market
Global Cell-based Assay Market Trend:
Increasing Demand for Targeted Therapies to Boost the Demand for Cell-based Assay – With progressions in scientific knowledge about diseases, there is a mounting focus on emerging targeted therapies that accurately address specific molecular pathways linked to ailments. The targeted therapies offer precision and effective treatment for diseases such as cancer, auto-immune diseases, etc. Therefore, bio-pharmaceutical companies such as Thermo Fisher Scientific, PerkinElmer, etc., are increasingly developing these targeted therapies to offer accurate treatment to patients suffering from deadly diseases. These targeted therapies are developed using cell-based assays since they provide valuable insights related to drug interfaces, latent side effects, and drug efficacy, driving the Global Cell-based Assay Market.
In addition, these biopharmaceutical companies are also investing in biomarkers for disease diagnosis, disease prognosis, and drug development, which would further stipulate the demand for cell-based assays.
Global Cell-based Assay Market Opportunity:
Personalized Medicine Unlocking Growth Potential in the Market – The rise of personalized medicine presents a significant opportunity in the Global Cell-based Assay Market. As genomics and precision medicine advance, there is a growing focus on tailoring medical treatments to individual patients based on their unique genetic profiles and disease characteristics. The increasing demand for personalized medicine necessitates accurate patient-specific drug assessments. Cell-based assays are crucial tools for evaluating individual drug responses and driving their demand. These assays enable tailored treatment selection, diverse patient population analysis, and data-driven healthcare in the growing personalized medicine market.
- In 2022, the company, Replimune Group, conducted a trial for the personalized medicine ‘vusolimogene oderparepvec (RP1)’, it developed for the treatment of melanoma patients.
Further, the bio-pharmaceutical companies are also integrating cell-based assays with emerging technologies like organ-on-a-chip and microfluidics to develop personalized medicine. The increasing amalgamation of these technologies with cell-based assays to revolutionize drug development & foster efficiency would consequently enhance the Global Cell-based Assay Market in forthcoming years.
For more detailed information about the Cell-based Assay market report, click here – https://www.marknteladvisors.com/research-library/cell-based-assay-market.html
Scope of the Report and Cell-based Assay Market Segmentation:
By Products & Services
- Consumables- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Reagents- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Assay Kits- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Reporter Gene Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Cell Growth Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Second Messenger Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Cell Death Assays- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Other (Ion Channel Assays, Cell Adhesion Assays, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Microplates
- Cell Lines
- Immortalized Cell Lines- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Primary Cell Lines- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Stem Cell Lines- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Probes & Labels- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Others (Microplates, Pipette Tips, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Instruments & Software- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Services- Market Size & Forecast 2019-2029, Revenues (USD Million)
By Application
- Drug Discovery- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Absorption, Distribution, Metabolism and Excretion (ADME) Studies- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Others (Basic Research, Predictive Toxicology Studies, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
By Technology
- Automated Handling- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Flow Cytometry- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Others (Label-free Detection, High-throughput Screening, etc.)- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Flow cytometry has become a dominant technology in the market due to its versatility and wide range of applicationsPharmaceutical & Biotechnological Companies- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Academic & Government Institutes- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Contract Research Organizations- Market Size & Forecast 2019-2029, Revenues (USD Million)
- Others (Research institutes, Contract Development and Manufacturing Organizations (CDMOs), etc.) – Market Size & Forecast 2019-2029, Revenues (USD Million)
Flow cytometry has become a dominant technology in the market due to its versatility and wide range of applications.
Cell-based Assay Market Development:
- 2023: Lunaphore Technologies and Cell Signaling Technology partnered to enable the use of CST’s antibodies on Lunaphore’s Comet platform for antibody-based spatial protein analysis. Utilizing fluorescent secondary antibodies, over 1,700 immunohistochemistry-validated antibodies from CST will be applied on the COMET platform for rapid antibody panel development.
Geographical Analysis:
By Region
- North America
- South America
- Europe
- The Middle East & Africa
- Asia-Pacific
The demand for Cell-based Assays in North America is influenced by its robust research and pharmaceutical sectors, clinical and diagnostic applications, stringent regulatory requirements, and global industry impact.
Note: If you require specific information not covered in the current report, we can provide it through customized option
Why choose Us?
MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.
For Media Inquiries, Please Contact:
Call: +1 628 895 8081 | +91 120 4278433
Email: sales@marknteladvisors.com
Sales Office: 564 Prospect St, B9, New Haven, Connecticut, USA-06511
Corporate Office: Office No.109, H-159, Sector 63, Noida, Uttar Pradesh-201301, India
